Back to dashboard
MedicaidCoverageMedium impact

New Clinical Guidelines: Coverage of the OVA1® (Multivariate Index Assay) Test pdf

Connecticut Medicaid (HUSKY Health)·CT · OB-GYN, Oncology·Provider Bulletin
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Connecticut Medicaid (HUSKY Health) has classified the OVA1® (Multivariate Index Assay) test as experimental and investigational, making it non-covered for all HUSKY program members. The test, used to assess ovarian cancer risk before surgery, will not be reimbursed due to insufficient clinical evidence.

Action Required

Action needed
Immediately: Billing teams must stop submitting claims for OVA1® (Multivariate Index Assay) tests for all Connecticut Medicaid HUSKY program members (HUSKY A, B, C, D, and Limited Benefit). Update billing system to flag these tests as non-covered for Connecticut Medicaid patients. Claims submitted will be denied as not medically necessary.